Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
181,259,081
-
Total 13F shares
-
21,137,514
-
Share change
-
+1,629,481
-
Total reported value
-
$335,200,000
-
Price per share
-
$15.86
-
Number of holders
-
50
-
Value change
-
+$24,348,825
-
Number of buys
-
29
-
Number of sells
-
15
Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q4 2021
As of 31 Dec 2021,
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,137,514 shares.
The largest 10 holders included
FMR LLC, Casdin Capital, LLC, FEDERATED HERMES, INC., RA CAPITAL MANAGEMENT, L.P., Avidity Partners Management LP, BlackRock Inc., Octagon Capital Advisors LP, MARSHALL WACE, LLP, Logos Global Management LP, and HHLR ADVISORS, LTD..
This page lists
50
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.